Category: Acute

BioXcel’s BXCL501 Receives the US FDA’s Breakthrough Therapy Designation for Acute Treatment of Agitation Associated with Dementia

Shots: The BTD is based on a P-Ib/II TRANQUILITY study assessing BXCL501 in patients with acute treatment of agitation associated with dementia, including AD The results demonstrated significant reductions in agitation measures @2hrs. post-dose with both 30 and 60 mcg doses as measured by multiple scales. The dose dependent response has the potential to support […]

Medtronic Launches Carpediem as the First Pediatric and Neonatal Acute Dialysis Machine in the US

Shots: Following the US FDA’s approval granted in early 2020, the first Carpediem (Cardio-Renal Pediatric Dialysis Emergency Machine) were installed & use at Cincinnati Children’s HMC in the US Carpediem system is indicated for acute kidney injury or fluid overloaded patients requiring hemodialysis or hemofiltration therapy The system is intended to provide CRRT to patients […]

AstraZeneca’s Brilinta (ticagrelor) Receives the US FDA’s Approval to Reduce the Risk of Stroke in Patients with an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Shots: The approval is based on P-III THALES study involves assessing Brilinta (180mg as a loading dose followed by 90mg, bid) + aspirin vs aspirin as monothx. in 11,000 patients with non-cardioembolic acute ischaemic stroke or high-risk TIA for 30days Results demonstrated a reduction in the rate of the composite 1EP of stroke & death […]